Antimicrobial Sales and Use (ASU) technical implementation protocol
Submitted by Anonymous (not verified) on 29 January 2024 - 12:48
Antimicrobial Sales and Use (ASU) technical implementation protocol
Antimicrobial Sales and Use (ASU) - Animal population data template
Submitted by Anonymous (not verified) on 29 January 2024 - 12:11
Antimicrobial Sales and Use (ASU) - Animal population data template
Antimicrobial Sales and Use (ASU) Power BI Application
Submitted by Anonymous (not verified) on 29 January 2024 - 11:25
Antimicrobial Sales and Use (ASU) Power BI Application
Antimicrobial Sales and Use (ASU) - Use data template
Submitted by Anonymous (not verified) on 29 January 2024 - 11:20
Antimicrobial Sales and Use (ASU) - Use data template
Antimicrobial Sales and Use (ASU) - Sales data template
Submitted by Anonymous (not verified) on 29 January 2024 - 11:15
Antimicrobial Sales and Use (ASU) - Sales data template
Antimicrobial Sales and Use (ASU) Platform User Guide
Submitted by Anonymous (not verified) on 29 January 2024 - 10:15
Antimicrobial Sales and Use (ASU) Platform User Guide
Production API and registration process - production release version 01.03 July 2021 - Veterinary Medicinal Products Regulation: Union Product Database
Submitted by Anonymous (not verified) on 26 January 2024 - 16:52
Production API and registration process - production release version 01.03 July 2021 - Veterinary Medicinal Products Regulation: Union Product Database
Applications for new human medicines under evaluation: January 2024
Submitted by Anonymous (not verified) on 26 January 2024 - 16:47
Applications for new human medicines under evaluation: January 2024
Orphan designation: lusvertikimab Treatment of acute lymphoblastic leukaemia, 25/07/2023 Positive
Submitted by Anonymous (not verified) on 26 January 2024 - 16:13
Orphan designation: lusvertikimab Treatment of acute lymphoblastic leukaemia, 25/07/2023 Positive
European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint meeting, European Medicines Agency, Amsterdam, the Netherlands, from 27 February 2024 to 28 February 2024
Submitted by Anonymous (not verified) on 26 January 2024 - 15:27
European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint meeting, European Medicines Agency, Amsterdam, the Netherlands, from 27 February 2024 to 28 February 2024